N National Healthcare Pvt. Ltd. को ब्रान्ड परिवार हो, नेपालमा बिक्री हुन्छ। NepalDoc सूचीमा यसका ५ वटा उत्पादन छन् — ३ वटा औषधि लाइनमा: Atropine Sulphate, Atropine Sulphate 1%, Prednisolone।
Atropine Sulfate Injection, USP, is indicated for temporary blockade of severe or life threatening muscarinic effects, e.g., as an antisialagogue, an antivagal agent, an antidote for organophosphorus or muscarinic mushroom poisoning, and to treat bradyasystolic cardiac arrest. Atropine is a muscarinic antagonist indicated for temporary blockade of severe or life threatening muscarinic effects.
From the U.S. FDA-approved label for Atropine Sulphate 1%. Full label: DailyMed.
Atropine Sulfate Injection, USP, is indicated for temporary blockade of severe or life threatening muscarinic effects, e.g., as an antisialagogue, an antivagal agent, an antidote for organophosphorus or muscarinic mushroom poisoning, and to treat bradyasystolic cardiac arrest. Atropine is a muscarinic antagonist indicated for temporary blockade of severe or life threatening muscarinic effects.
From the U.S. FDA-approved label for Atropine Sulphate 1%. Full label: DailyMed.
For intravenous administration.. Titrate according to heart rate, PR interval, blood pressure and symptoms. Adult dosage Antisialagogue or for antivagal effects: Initial single dose of 0.5 to 1 mg.
Directions from the U.S. FDA-approved label for Atropine Sulphate 1% — your doctor or pharmacist may advise differently.
Tachycardia Glaucoma Pyloric obstruction Worsening urinary retention Viscid bronchial plugs 5.1 Tachycardia When the recurrent use of atropine is essential in patients with coronary artery disease, the total dose should be restricted to 2 to 3 mg (maximum 0.03 to 0.04 mg/kg) to avoid the detrimental effects of atropine-induced tachycardia on myocardial oxygen demand. 5.2 Acute Glaucoma Atropine may precipitate acute glaucoma. 5.3 Pyloric Obstruction Atropine may convert partial organic pyloric stenosis into complete obstruction.
Warnings and precautions excerpt from the U.S. FDA-approved label for Atropine Sulphate 1% — not a complete list. Talk to a pharmacist or doctor before use.
The following adverse reactions have been identified during post-approval use of atropine sulfate. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. Most of the side effects of atropine are directly related to its antimuscarinic action.
Excerpt from the U.S. FDA-approved label for Atropine Sulphate 1% — not a complete list. Talk to a pharmacist or doctor about side effects.
२ ब्रान्ड · २ निर्माता — NepalDoc सूचीमा — पूरै Atropine Sulphate 1% गाइड हेर्नुहोस् →
Store at 20°C to 25°C (68°F to 77°F);
Storage information from the U.S. FDA-approved label for Atropine Sulphate 1%.
N Pin के हो?
N Pin 1% + 0.025 Eye Drop भनेको Atropine Sulphate 1% औषधि हो, National Healthcare Pvt. Ltd. ले बनाएको। यो 1% + 0.025 Eye Drop रूपमा पाइन्छ।
N Pin को सामान्य नाम के हो?
N Pin को सामान्य नाम Atropine Sulphate 1% हो।
नेपालमा Atropine Sulphate 1% का कुन कुन ब्रान्ड उपलब्ध छन्?
NepalDoc सूचीमा Atropine Sulphate 1% का २ वटा ब्रान्ड छन्, २ निर्माताबाट — जसमा Attropin 1%W/V Eye Drop पर्छन्।
N Pin को मूल्य नेपालमा कति हो?
NepalDoc ले औषधिको मूल्य सूचीबद्ध गर्दैन। मूल्य हरेक फार्मेसीले आफैं तय गर्छ र समयसँगै परिवर्तन हुन्छ — यो पृष्ठले नेपालमा बिक्री हुने ब्रान्ड, यसको सामान्य नाम, निर्माता, शक्ति र प्याक विवरण पुष्टि गर्छ, ताकि तपाईं आफ्नो फार्मेसीमा मूल्य विश्वस्त भएर सोध्न सक्नुहोस्।
यो पृष्ठ सामान्य जानकारीका लागि मात्र हो, चिकित्सकीय सल्लाह होइन। औषधिको विवरण माथि उल्लेखित स्रोतहरूबाट आएको हो र परिवर्तन हुन सक्छ — प्रयोग गर्नुअघि डाक्टर वा फार्मासिस्टसँग औषधि, शक्ति र मात्रा पुष्टि गर्नुहोस्। सूचीमा हुनुले कुनै फार्मेसीमा औषधि उपलब्ध छ भन्ने ग्यारेन्टी दिँदैन।
नेपालडकका सबै खण्ड, एकै ठाउँमा।